Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

169 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Persistent low-level variants in a subset of viral genes are highly predictive of poor outcome in immunocompromised patients with cytomegalovirus infection.
Venturini C, Colston JM, Charles O, Lankina A, Best T, Atkinson C, Forrest C, Williams CA, Rao K, Worth A, Thorburn D, Harber M, Griffiths P, Breuer J. Venturini C, et al. Among authors: harber m. J Infect Dis. 2024 Jan 5:jiae001. doi: 10.1093/infdis/jiae001. Online ahead of print. J Infect Dis. 2024. PMID: 38181168
Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy.
Atabani SF, Smith C, Atkinson C, Aldridge RW, Rodriguez-Perálvarez M, Rolando N, Harber M, Jones G, O'Riordan A, Burroughs AK, Thorburn D, O'Beirne J, Milne RS, Emery VC, Griffiths PD. Atabani SF, et al. Among authors: harber m. Am J Transplant. 2012 Sep;12(9):2457-64. doi: 10.1111/j.1600-6143.2012.04087.x. Epub 2012 May 17. Am J Transplant. 2012. PMID: 22594993 Free PMC article.
Randomized Controlled Trials to Define Viral Load Thresholds for Cytomegalovirus Pre-Emptive Therapy.
Griffiths PD, Rothwell E, Raza M, Wilmore S, Doyle T, Harber M, O'Beirne J, Mackinnon S, Jones G, Thorburn D, Mattes F, Nebbia G, Atabani S, Smith C, Stanton A, Emery VC. Griffiths PD, et al. Among authors: harber m. PLoS One. 2016 Sep 29;11(9):e0163722. doi: 10.1371/journal.pone.0163722. eCollection 2016. PLoS One. 2016. PMID: 27684379 Free PMC article.
Cytomegalovirus viral load parameters associated with earlier initiation of pre-emptive therapy after solid organ transplantation.
Lumley S, Green C, Rafferty H, Smith C, Harber M, O'Beirne J, Jones G, Thorburn D, Marshall A, Shah T, Zuhair M, Rothwell E, Atabani S, Haque T, Griffiths P. Lumley S, et al. Among authors: harber m. PLoS One. 2019 Jan 25;14(1):e0210420. doi: 10.1371/journal.pone.0210420. eCollection 2019. PLoS One. 2019. PMID: 30682032 Free PMC article.
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial.
Griffiths PD, Stanton A, McCarrell E, Smith C, Osman M, Harber M, Davenport A, Jones G, Wheeler DC, O'Beirne J, Thorburn D, Patch D, Atkinson CE, Pichon S, Sweny P, Lanzman M, Woodford E, Rothwell E, Old N, Kinyanjui R, Haque T, Atabani S, Luck S, Prideaux S, Milne RS, Emery VC, Burroughs AK. Griffiths PD, et al. Among authors: harber m. Lancet. 2011 Apr 9;377(9773):1256-63. doi: 10.1016/S0140-6736(11)60136-0. Lancet. 2011. PMID: 21481708 Free PMC article. Clinical Trial.
169 results